Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Peritoneal Carcinomatosis From Ovarian Cancer”

10 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 10 results

Large-scale testing (Phase 3)UnknownNCT02328716
What this trial is testing

Cytoreduction With or Without Intraoperative Intraperitoneal Hyperthermic Chemotherapy (HIPEC) in Patients With Peritoneal Carcinomatosis From Ovarian Cancer, Fallopian Tube or Primary Peritoneal Carcinoma

Who this might be right for
Peritoneal Carcinomatosis From Ovarian CancerFallopian Tube CarcinomaPrimary Peritoneal Carcinoma
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia 32
Testing effectiveness (Phase 2)Study completedNCT02739698
What this trial is testing

Role of Intraperitoneal Intraoperative Chemotherapy With Paclitaxel in the Surgical Treatment of Peritoneal Carcinomatosis From Ovarian Cancer. Hyperthermia Versus Normothermia

Who this might be right for
Peritoneal Carcinomatosis
Maimónides Biomedical Research Institute of Córdoba 32
Not applicableEnded earlyNCT02803515
What this trial is testing

Hyperthermic Intraperitoneal Chemotherapy (HIPEC) : Predictive Marker and Mechanism

Who this might be right for
Peritoneal Carcinomatosis
Centre Hospitalier Universitaire de Nice 12
Early research (Phase 1)Looking for participantsNCT04847063
What this trial is testing

Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies

Who this might be right for
Peritoneal MesotheliomaPeritoneal CarcinomatosisOvarian Cancer+4 more
National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)Study completedNCT02604784
What this trial is testing

Study of Efficacy and Safety of Laparoscopic Intra-abdominal Chemotherapy (PIPAC) Performed in Patients With Peritoneal Carcinomatosis From Colorectal, Ovarian, Gastric Cancer and Primary Peritoneal Tumors

Who this might be right for
Peritoneal Carcinomatosis
Fondazione del Piemonte per l'Oncologia 105
Not applicableEnded earlyNCT01685632
What this trial is testing

Intra Peritoneal Chemo Hyperthermia (IPCH) : Cellular and Metabolic Consequences

Who this might be right for
Peritoneal Carcinomatosis From Colorectal or Ovarian Origin
Centre Hospitalier Universitaire de Nice 60
Not applicableStudy completedNCT06789224
What this trial is testing

Validation Study on the Removal of EpCAM-positive Tumour Cells From Blood Collected During Tumour Surgery Using Catumaxomab/Catuvab Device

Who this might be right for
Bladder CarcinomaProstate TumorGallbladder Carcinoma+9 more
Lindis Bloodcare GmbH 136
Not applicableStudy completedNCT03931304
What this trial is testing

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Peritoneal Carcinomatosis From Ovarian Cancer (Cyto-chip 2)

Who this might be right for
Peritoneal CarcinomaOvarian Cancer
Hospices Civils de Lyon 1,200
Testing effectiveness (Phase 2)Study completedNCT01834469
What this trial is testing

Imaging of Peritoneal Carcinomatosis From Ovarian Carcinoma Patients

Who this might be right for
Ovarian CancerPeritoneal Carcinomatosis
Jules Bordet Institute 10
Testing effectiveness (Phase 2)Study completedNCT05185947
What this trial is testing

Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis

Who this might be right for
Gynecologic CancerGynecologic NeoplasmsPeritoneal Carcinomatosis+9 more
National Cancer Institute (NCI) 21